Abstract
It is generally accepted that intellectual functioning decreases slowly from the third decade of life to the sixth and more abruptly thereafter. General intelligence, as evaluated by environmental criteria, appears to be maintained over a much greater period of adult life and to decline at a much slower rate than does mental ability as assessed in certain types of intelligence tests. There are exceptional individuals who retain remarkable intellectual powers throughout their lives. Their brains are presumably free of gross pathology, indeed plaques and tangles are not invariably present in the brains of all elderly individuals. Thus it is not mandatory for ageing to be associated with cognitive loss accompanied by neuropathological changes. In the opinion of Wisniewski and Merz (1984) measurable and visible variation from normal brain structure function is, by definition, pathological. If by reason of their number and location, these pathological changes elicit a clinical expression, they are defined as disease. Although gerontologists seem to avoid discussion of illness, Wisniewski and Merz (1984) argue that ‘normal aging’ may simply be a stage of pathology without clinical expression.
Preview
Unable to display preview. Download preview PDF.
References
Anderson, J. M., Hubbard, B. M., Coghill, G. R., and Slidders, W. (1983). The effect of advanced old age on the neurone content of the cerebral cortex — observations with an automatic image analyser point counting method. J. Neurol Sci., 58, 235–46.
Anderton, B. H., Breinburg, D., Downes, M. J., Green, P. J., Tomlinson, B. E., Ulrich, J., Wood, J. N., and Kahn, J. (1982). Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature, 298, 84–6.
Appel, S. H., (1981). A unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinsonism and Alzheimer’s disease. Ann. Neurol., 10, 499–505.
Ball, M. J. (1977). Neuronal loss, neuro-fibrillary tangles and granulovascular degeneration in the hippocampus with ageing and dementia. Acta Neuropath. (Berl.), 37, 111–18.
Ball, M. J. (1982). Limbic predilection in Alzheimer dementia: Is reactivated herpesvirus involved?. Canad. J. Neurol. Sci., 9, 303–6.
Barclay, L. L., Kheyfets, S., Zemcov, A., and McDowell, F. H. (1985). Genetic factors in Alzheimer’s disease. J. Neurol. (Suppl.), 232, 61.
Bowen, D. M., and Davison, A. N. (1985). Importance of acetylcholine and tangle-bearing cortical neurones in Alzheimer’s disease. Proc. 5th Mtng Eur. Soc. Neurc, 17, 275–8.
Brody, H. (1955). Organization of cerebral cortex: III. A study of aging in the human cerebral cortex. J. Comp. Neurol., 102, 511–56.
Brun, A. (1983). An overview of light and electron microscopic changes. In Reisberg, B. (ed.), Alzheimer’s Disease. The Free Press, New York, pp. 37–47.
Buell, S. J., and Coleman, P. D. (1979). Dendritic growth in the aged human brain and failure of growth in senile dementia. Science, 206, 854–5.
Candy, J. M., Oakley, A. E., Klinowski, J., Carpenter, T. A., Perry, R. H., Atack, J. R., Perry, E. K., Blessedj G., Fairbairn, A., and Edwaidson, J. A. (1986). Aluminosilicates contribute to senile plaque formation in Alzheimer’s disease. Lancet (in press).
Cotman, C. W., and Scheff, S. W. (1979). Compensatory synapse growth in aged animals after neuronal death. Mech. Aging and Devel., 9, 103–11.
Damasio, H., Eslinger, P., Damasio, A. R., Rizzo, M., Huang, H. K., and Demeter, S. (1983). Quantitative computed tomographic analysis in the diagnosis of dementia. Arch. Neurol., 40, 715–19.
Dekaban, A. S. (1978). Changes in brain weights during the span of human life: Relation of brain weights to body heights and body weights. Ann. Neurol., 4, 345–56.
Fine, A., Dunnett, S. B., Bjorklund, A., and Iversen, S. D. (1985). Cholinergic ventral fore-brain grafts into the neocortex improve passive avoidance memory in a rat model of Alzheimer disease. Proc. Nat. Acad. Sci. USA, 82, 5227–31.
Foster, N. L., Chase, T. N., Fedio, P., Patronas, N. J., Brooks, R. A., and Di Chiro, G. (1983). Alzheimer’s disease: Focal cortical changes shown by positron emission tomography. Neurology, 33, 961–5.
Francis, P. T., Palmer, A. M., Sims, N. R., Bowen, D. M., Davison, A. N., Esiri, M. M., Neary, D., Snowden, J. S., and Wilcock, G. K. (1985). Neurochemical studies of early-onset Alzheimer’s disease. Possible influence on treatment. New Eng. J., 313, 7–11.
Geinisman, Y., Bondareff, W., and Telser, A. (1977). Transport of [3H] fucose labelled glycoproteins in the septo-hippocampai pathway of young adult and senescent rats. Brain Res., 125, 182–6.
Greenamyre, J. T., Young, A. B., Penney, J. B., D’Amato, C. J., Hicks, S. P., and Shoulson, I. (1985). Alterations in L-glutamate binding in Alzheimer’s and Huntington’s diseases. Science, 227, 1496–9.
Hachinski, V. C. (1983). Differential diagnosis of Alzheimer’s dementia: Multi-infarct dementia. In Reisberg, B. (ed), Alzheimer’s Disease. The Free Press, New York, 188–92.
Harman, D. (1981). The aging process. Proc. Natl. Acad. Sci. USA, 78, 7124–8.
Henderson, G., Tomlinson, B. E., and Gibson, P. H. (1980). Cell counts in human cerebral cortex in normal adults throughout life using an image analysing computer. J. Neurol. Sci., 46, 113–36.
Hubbard, B. M., and Anderson, J. M. (1981). A quantitative study of cerebral atrophy in old age and senile dementia. J. Neurol. Sci., 50, 135–45.
Hubbard, B. M., and Anderson, J. M. (1986). Age-related variations in the neurone content of the cerebral cortex in senile dementia of Alzheimer type. Neuropath. & Appl. Neuro-biol. (in press).
Ishii, T. (1966). Distribution of Alzheimer’s neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta Neuropathol. (Berl.), 6, 181–7.
Konigsmark, B. W., and Murphy, E. A. (1970). Neuronal populations in the human brain. Nature, 228, 1335–6.
Li, J. C., and Kaminskas, E. (1985). Deficient repair of DNA lesions in Alzheimer’s disease fibroblasts. Biochem & Biophys. Res. Comm., 129, 733–8.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of dept. of health and human services task force on Alzheimer’s disease. Neurology, 34, 939–44.
Mann, D. M. A., Neary, D., Yates, P. O., Lincoln, J., Snowden, J. S., and Stanworth, P. (1981). Alterations in protein synthetic capability of nerve cells in Alzheimer’s disease. J. Neurol Neurosurg. Psychiat., 44, 97–103.
Mann, D. M. A., Yates, P. O., and Marcyniuk, B. (1984). Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer’s disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mechanisms Ageing and Develop., 25, 189–204.
Mann, D. M. A., Yates, P. O., and Marcyniuk, B. (1985). Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer’s disease, senile dementia of Alzheimer type and Down’s syndrome in middle age. J. Neurol. Sci., 69, 139–59.
Masters, C. L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R. N., and Beyreuther, K. (1985a). Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer’s disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO, J., 4 (in press).
Masters, C. L., Simms, G., Weinman, N. A., Malthaup, G., McDonald, B. L., and Beyreuther, K. (1985b). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Nat. Acad. Sci. USA, 82, 4245–9.
Monagle, R. D., and Brody, H. (1971). The effects of age upon the main nucleus of the inferior olive in the human. J. Comp. Neurol., 155, 61–6.
Mountjoy, C. Q., Roth, M., Evans, N. J. R., and Evans, H. M. (1983). Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol. of Aging, 4, 1–11.
Nieto-Sampedro, M., Manthrope, M., Barbin, G., Varon, S., and Cotman, C. W. (1983). Injury-induced neuronotrophic activity in adult rat brain: correlation with survival of delayed implants in the wound cavity. J. Neurosci., 3, 2219–29.
Oldstone, M. B. A., Holmstoen, J., and Welsh, R. M. Jr. (1977). Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus. J. Cellular Physiol., 91, 459–72.
Pearce, B. R., Palmer, A. M., Bowen, D. M., Wilcock, G. K., Esiri, M. M., and Davison, A. N. (1984). Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer’s disease. Neurochem. Path., 2, 221–3.
Pearson, R. C. A., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., and Powell, T. P. S. (1985). Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl Acad. Sci. USA, 82, 1–4.
Pearson, R. C. A., Gatter, K. C., and Powell, T. P. S. (1983b). Retrograde cell degeneration in the basal nucleus in monkey and man. Brain Res., 261, 321–6.
Pearson, R. C. A., Sofroniew, M. V., Cuello, A. C., Powell, T. P. S., Eckenstein, F., Esiri, M. M., and Wilcock, G. K. (1983a). Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer’s type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res., 289, 375–9.
Perry, E. K., Curtis, M., Dick, D. J., Candy, J. M., et al. (1985). Cholinergic correlates of cognitive impairment in Parkinson’s disease — comparisons with Alzheimer’s disease. J. Neurol. Neurosurg. Psychiat., 48, 413–22.
Perry, R. H. (1984). Neuropathology of Dementia. In Pearce, J. M. S. (ed.), Dementia: A Clinical Approach. Blackwells, London, pp. 89–116.
Perry, R. H., Candy, J. M., Perry, E. K., Irving, D., Blessed, G., Fairbairn, A. F., and Tomlinson, B. E. (1982). Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer’s disease. Neurosci. Lett., 33, 311–15.
Robison, S. H., Munzer, J. S., Tandan, R., Bradley, R. S., and Bradley, W. G. (1985). DNA repair replication of alkylated DNA is reduced in Alzheimer’s disease cells. J. Neurology (Suppl.), 232, 63.
Rossor, M. N. (1981). Parkinson’s disease and Alzheimer’s disease as disorders of the iso-dendritic core. Brit. Med. J., 283, 1588–90.
Rubenstein, R., and Price, R. W. (1984). Early inhibition of acetylcholinesterase and choline acetyltransferase activity in herpes simplex virus type 1 infection of PC12 cells. J. Neurochem., 42, 142–50.
Sajdel-Sulkowska, E. M., and Marotta, C. A. (1984). Alzheimer’s disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex. Science, 225, 947–9.
Sasaki, H., Muramoto, O., Kanazawa, I., Arai, H., Kosaka, K., and Iizuka, R. (1985). Selective reduction of glutamate in the postmortem brains of Alzheimer’s disease. J. Neurology (Suppl to vol. 232), 232, 11.
Schiebel, A. B., and Tomiyasu, U. (1978). Dendritic sprouting in Alzheimer’s pre-senile dementia. Exp. Neurol., 60, 1–8.
Schwab, M. E., Otten, U., Agid, Y., and Thoenen, H. (1979). Nerve growth factor (NGF) in the rat CNS: absence of specific retrograde axonal transport and tyrosine hydroxylase induction in locus coeruleus and substantia nigra. Brain Res., 168, 473–83.
Selkoe, D. J., Abraham, C., and Rasool, C. G. (1985a). Molecular properties of paired helical filaments and senile plaque amyloid fibers in Alzheimer’s disease. 30th Oholobiological Conf., 25.
Selkoe, D. J., Abraham, C., and Rasool, C. G. (1985b). Basic and Therapeutic Strategies in Alzheimer’s and other Age-related Neuropsychiatric Disorders. Edited and published by the Israel Institute for Biological Research.
Sims, N. R., Bowen, D. M., Allen, S. J., Smith, C. C. T., Neary, D., Thomas, D. J., and Davison, A. N. (1983). Presynaptic cholinergic dysfunction in patients with dementia. J. Neurochem., 40, 503–9.
Smith, C. C. T., Bowen, D. M., Francis, P. T., Snowden, J. S., and Neary, D. (1985). Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer’s dementia. J. Neurol. Neurosurg. Psychiat., 48, 469–72.
Sofroniew, M. V., Pearson, R. C. A., Eckenstein, F., Cuello, A. C., and Powell, T. P. S. (1983). Retrograde changes in cholinergic neurons in the basal forebrain of the rat following cortical damage. Brain Res., 289, 370–4.
Sourander, P., and Sjogren, H. (1970). The concept of Alzheimer’s disease and its clinical implications. In Wolstenholme, G. E. W. and O’Connor, M. E. (eds.) Alzheimer’s Disease and Related Conditions. Churchill, London, pp. 11–32.
Terry, R. D., Peck, A., De Teresa, R., Schechter, R., and Horoupian, D. S. (1981). Some morphometric aspects of the brain in senile dementia of the Alzheimer’s type. Ann. Neurol., 10, 184–92.
Tomlinson, B. E. (1980). The structural and quantitative aspects of the dementias. In Roberts, P. J. (ed.), Biochemistry of Dementia. Wiley, Chichester, pp. 15–52.
Tomlinson, A. H., and Esiri, M. M. (1983). Herpes simplex encephalitis: Immunohistological demonstration of spread of virus via olfactory pathways in mice. J. Neurol. Sci., 60, 473–84.
Tomlinson, B. E., Irving, D., and Blessed, G. (1981). Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J. neurol. Sci., 49, 419–28.
White, P., Hiley, C. R., Goodhardt, M. J., Carrasco, L., Keet, J. P., Williams, J. E. J., and Bowen, D. M. (1977). Neocortical cholinergic neurones in elderly people. Lancet, i, 668–70.
Whitehouse, P. J., Price, D. L., Struble, R. G., Clark, A. W., Coyle, J. T., and Delong, M. R. (1982). Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science, 215, 1237–9.
Winblad, B., Adolfsson, R., Gottfries, C. G., Oreland, L., and Roos, E. B. (1978). Brain monoamines, monoamine metabolites and enzymes in physiological ageing and senile dementia. In Frigerio, A. (ed.), Recent Developments in Mass Spectrometry in Biochemistry and Medicine. Plenum, New York, pp. 253–67.
Wisniewski, H. M., and Merz, G. S. (1984). Neuropathology of the aging brain and dementia of the Alzheimer type. In Gaitz, C., and Samorajski, T. (eds.), Aging 2000: Our Health Care Destiny.
Editor information
Editors and Affiliations
Copyright information
© 1986 The Editors and the Contributors
About this chapter
Cite this chapter
Davison, A.N. (1986). New Concepts in the Pathophysiology of Alzheimer’s Disease. In: Briley, M., Kato, A., Weber, M. (eds) New Concepts in Alzheimer’s Disease. Palgrave, London. https://doi.org/10.1007/978-1-349-08639-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-349-08639-9_1
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-08641-2
Online ISBN: 978-1-349-08639-9
eBook Packages: MedicineMedicine (R0)